We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Fast Diagnostic Tool Investigated for Wound Infections

By LabMedica International staff writers
Posted on 29 Aug 2011
A novel concept for a fast diagnostic tool for wound infection based on enzymes triggered release of dye from a polymeric matrix has been investigated.

For the development of a simple diagnostic tool, a liquid lysozyme assay was adapted to a solid system and the matrix consisted of alginate/agarose and peptidoglycan covalently labeled with Remazol brilliant blue. More...


Scientists from the Graz University of Technology (Austria) collected wound fluid from 10 postoperative wounds, 8 decubitus ulcer wounds, and 8 blisters and analyzed by biochemical techniques. The detection of wound infection was based on lysozyme and elastase triggered release of the dye from a peptidoglycan matrix. Incubation of 8% labeled agarose/peptidoglycan blend layers with infected wound fluid samples for two hours at 37 °C resulted in a four-fold higher amount of dye released than measured for noninfected wounds. Lysozyme activity in postoperative wounds and decubitus (bed sore) wound fluids was significantly elevated upon infection (4,830 ± 1,848 U/mL), compared to noninfected wounds (376 ± 240 U/mL).

A seven-fold higher amount of dye was released in case of infected wound fluid samples compared to noninfected ones using an alginate/peptidoglycan beads assay. By using Western blotting techniques, proteases including the gelatinase matrix metalloproteinases MMP-2 and MMP-9, and elastase were detected in wound fluids. A slight synergistic effect was measured by dye release for peptidoglycan hydrolysis, between lysozyme and these proteases. Incubation of a double-layer system consisting of stained and nonstained peptidoglycan with infected wound fluids resulted in a color change from yellow to blue, thus allowing simple visual detection of wound infection.

The authors concluded that such a diagnostic tool would allow early intervention with suitable treatment and could reduce clinical intervention and the use of antibiotics. The tool is based on human enzymes, which can be detected in wound fluid samples in a very fast way and which were shown to be elevated in case of infection. The study was published in September 2011, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Graz University of Technology





Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Rapid Test Reader
DIA5000
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.